Long-term follow-up of 1,000 patients cured of helicobacter pylori infection following an episode of peptic ulcer bleeding

American Journal of Gastroenterology

Volumn 107, Issue 8, 2012, Pages 1197-1204

  Gisbert, J P ^a   Calvet, X ^b   Cosme, A ^c   Almela, P ^d   Feu, F ^e   Bory, F ^f   Santolaria, S ^g   Aznarez R ^h   Castro, M ⁱ   Fernandez N ^j   Garcia Gravalos R ^a   Benages, A ^d   Caete N ^f   Montoro, M ^g   Borda, F ^h   Perez Aisa A ^j   Pique J M ^e  

^a Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g HOSPITAL SAN JORGE   (Spain)

^h Universidad Pública de Navarra   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^j Agencia Sanitaria Costa Del Sol   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE; RIFABUTIN; TETRACYCLINE;

ADULT; ARTICLE; DISEASE COURSE; DRUG USE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REINFECTION; STOMACH ULCER; TREATMENT OUTCOME;

BREATH TESTS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; RECURRENCE; UREA;

EID: 84864594440     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.132     Document Type: Article

References (57)

1. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 717-27. (Pubitemid 24275746)
2. Mignon M, Penston JG, Deltenre M et al. Natural history of duodenal ulcer disease: are we at a turning point? Gastroenterol Int 1994; 7: 95-113.
3. Laine LA. H elicobacter pylori and complicated ulcer disease. A m J Med 1996; 100: 52S-7S; discussion 7S-9S.
4. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Th er 2011; 33: 585-91.
5. Murray WR, Cooper G, Laferla G et al. Maintenance ranitidine treatment aft er haemorrhage from a duodenal ulcer. A 3-year study. J Gastroenterol 1988; 23: 183-7. (Pubitemid 18096830)
6. Jensen DM, Cheng S, Kovacs TO et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994; 330: 382-6. (Pubitemid 24045654)
7. Gisbert JP, Calvet X. Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Th er 2009; 30: 791-815.
8. Gisbert JP, Pajares JM. H elicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication? Scand J Gastroenterol 2003; 38: 2-9. (Pubitemid 36152857)
9. Hopkins RJ, Girardi LS, Turney EA. Relationship between H elicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52. (Pubitemid 26113765)
10. NIH Consensus Conference. H elicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Jama 1994; 272: 65-9.
11. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. Jama 1996; 275: 622-9.
12. Gisbert JP, Khorrami S, Carballo F et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev 2004; 2: CD004062.
13. Leontiadis GI, Sreedharan A, Dorward S et al. Systematic reviews of the clinical eff ectiveness and cost-eff ectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007; 11: iii-iiv, 1-164.
14. Gisbert JP, Calvet X, Feu F et al. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Helicobacter 2007; 12: 279-86. (Pubitemid 47196329)
15. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 848-63.
16. Gisbert JP, Badia X, Roset M et al. The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice. Helicobacter 2004; 9: 28-38. (Pubitemid 38250064)
17. Gisbert JP, Gonzalez L, de Pedro A et al. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-infl ammatory drugs. Scand J Gastroenterol 2001; 36: 717-24. (Pubitemid 32568549)
18. Guell M, Artigau E, Esteve V et al. Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer. Aliment Pharmacol Th er 2006; 23: 53-9. (Pubitemid 43381166)
19. Sanchez-Delgado J, Gene E, Suarez D et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 2011; 106: 398-405.
20. Amendola M, Farias R, Katz J et al. Absence of bleeding recurrence of peptic ulcer aft er long term follow-up of successful eradication of Helicobacter pylori. Acta Gastroenterol Latinoam 1999; 29: 47-50.
21. Arkkila PE, Seppala K, Kosunen TU et al. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol 2003; 98: 2149-56. (Pubitemid 37305351)
22. Capurso G, Annibale B, Osborn J et al. Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection. Aliment Pharmacol Th er 2001; 15: 821-9. (Pubitemid 32500428)
23. Gisbert JP, Boixeda D, Aller R et al. Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the effi cacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence. Med Clin (Barc) 1999; 112: 161-5. (Pubitemid 29100463)
24. Graham DY, Hepps KS, Ramirez FC et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-42. (Pubitemid 23312236)
25. Horvat D, Vcev A, Soldo I et al. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer. Coll Antropol 2005; 29: 139-42. (Pubitemid 40978256)
26. Jaspersen D, Koerner T, Schorr W et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 5-7.
27. Jaspersen D, Korner T, Schorr W et al. Omeprazole-amoxycillin therapy for eradication of Helicobacter pylori in duodenal ulcer bleeding: preliminary results of a pilot study. J Gastroenterol 1995; 30: 319-21.
28. Krizman I, Ribnikar M, Kozjek F et al. Comparative amoxicillin- Azithromycin treatment of Helicobacter pylori positive patients with bleeding duodenal ulcer. Acta Pharmaceutica 1997; 47: 183-8. (Pubitemid 27461656)
29. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
30. Lai KC, Hui WM, Wong WM et al. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage-a long-term randomized, controlled study. Am J Gastroenterol 2000; 95: 2225-32.
31. Liu CC, Lee CL, Chan CC et al. Maintenance treatment is not necessary aft er Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Arch Intern Med 2003; 163: 2020-4.
32. Macri G, Milani S, Surrenti E et al. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol 1998; 93: 925-7. (Pubitemid 29076978)
33. Pellicano R, Peyre S, Leone N et al. The eff ect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer. J Clin Gastroenterol 2001; 32: 222-4. (Pubitemid 32174113)
34. Riemann JF, Schilling D, Schauwecker P et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc 1997; 46: 299-304. (Pubitemid 27459264)
35. Rokkas T, Karameris A, Mavrogeorgis A et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
36. Santander C, Gravalos RG, Gomez-Cedenilla A et al. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996; 91: 1549-52.
37. Sung JJ, Leung WK, Suen R et al. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci 1997; 42: 2524-8. (Pubitemid 28103791)
38. Vcev A, Horvat D, Rubinic M et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in duodenal ulcer disease. Acta Fam Med Flum 1996; 21: 59-65. (Pubitemid 28177454)
39. Vergara M, Casellas F, Saperas E et al. Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage. Eur J Gastroenterol Hepatol 2000; 12: 733-7. (Pubitemid 30496696)
40. Sharma VK, Sahai AV, Corder FA et al. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Th er 2001; 15: 1939-47. (Pubitemid 34014350)
41. Gene E, Calvet X, Azagra R. Diagnosis of Helicobacter pylori aft er triple therapy in uncomplicated duodenal ulcers-a cost-eff ectiveness analysis. Aliment Pharmacol Th er 2000; 14: 433-42. (Pubitemid 30199220)
42. Ofman J, Wallace J, Badamgarav E et al. The cost-eff ectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage. Am J Gastroenterol 2002; 97: 1941-50.
43. Ghoshal UC, Aggarwal R, Baba CS. Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategies. Expert Opin Pharmacother 2003; 4: 1593-603. (Pubitemid 37120905)
44. Pohl H, Finlayson SR, Sonnenberg A et al. Helicobacter pylori-associated ulcer bleeding: should we test for eradication aft er treatment? Aliment Pharmacol Th er 2005; 22: 529-37. (Pubitemid 41360799)
45. Gisbert JP, Pajares JM. Helicobacter pylori ' rescue' therapy aft er failure of two eradication treatments. Helicobacter 2005; 10: 363-72. (Pubitemid 41368693)
46. Gisbert JP, Gisbert JL, Marcos S et al. Empirical rescue therapy aft er Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Th er 2008; 27: 346-54.
47. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables infl uencing it. A critical review. Am J Gastroenterol 2005; 100: 2083-99.
48. Gisbert JP, Luna M, Gomez B et al. Recurrence of Helicobacter pylori infection aft er several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Th er 2006; 23: 713-9. (Pubitemid 43344589)
49. Niv Y. H pylori recurrence aft er successful eradication. World J Gastroenterol 2008; 14: 1477-8. (Pubitemid 351460158)
50. Barthel JS. Bleeding ulcers and Helicobacter pylori. Gastrointest Endosc 1997; 46: 371-3. (Pubitemid 27459282)
51. Vergara M, Catalan M, Gisbert JP et al. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Th er 2005; 21: 1411-8. (Pubitemid 40874157)
52. Chan FK, Chung SC, Suen BY et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-73. (Pubitemid 32240315)
53. Lai KC, Lam SK, Chu KM et al. Lansoprazole reduces ulcer relapse aft er eradication of Helicobacter pylori in nonsteroidal anti-infl ammatory drug users-a randomized trial. Aliment Pharmacol Th er 2003; 18: 829-36. (Pubitemid 37323649)
54. Lai KC, Lam SK, Chu KM et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-8. (Pubitemid 34680594)
55. Hood HM, Wark C, Burgess PA et al. Screening for Helicobacter pylori and nonsteroidal anti-infl ammatory drug use in medicare patients hospitalized with peptic ulcer disease. Arch Intern Med 1999; 159: 149-54. (Pubitemid 29055102)
56. Garrigan K, McIntosh C, Fraser AG. Bleeding peptic ulcers: audit of eradication treatment for H pylori. N Z Med J 1999; 112: 178-80. (Pubitemid 29265818)
57. van Leerdam ME, Tytgat GN. Review article: Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Th er 2002; 16 (Suppl 1): 66-78. (Pubitemid 41759570)